KN060 for treating high blood pressure
Part of Heart & circulation clinical trials.
This trial tests a new medication called KN060 for people with high blood pressure (essential hypertension). It is for those who are not on medication or are on a stable single medication, and whose blood pressure is moderately high but not extremely high.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have high blood pressure (essential hypertension) and are either not taking any medication or are on a single medication that hasn't changed in the last 30 days.
- Your blood pressure measured in the office is between 140 and 179 (top number) and your 24-hour average is between 130 and 160.
- You do not have high blood pressure caused by another condition (like kidney disease or sleep apnea).
- You are not taking blood thinners or antiplatelet drugs (like aspirin) and have not had a heart attack or stroke in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, GW906, given as an injection alongside your current blood pressure pills. It aims to help people whose blood pressure is still too high even with one or two medications.
This study tests a standardized plan for treating high blood pressure (hypertension). It's for people whose blood pressure is above 140/90 and who are either newly diagnosed or on only one medication, to see if following a consistent treatment approach helps lower blood pressure more effectively.
This study tests a new blood pressure medication to see if it is safe and effective for people with high blood pressure. It may help lower your blood pressure and reduce health risks.
This study tests a new investigational medicine called VB19055 for people whose high blood pressure is not controlled even though they are already taking multiple blood pressure medications. The trial aims to see if this new drug can help lower blood pressure more effectively.
This trial tests a new treatment called CTX340 for high blood pressure that is hard to control even with multiple medications. The study aims to see if it is safe and effective.
This early-stage trial tests a new oral medication (HS-10522) to see if it is safe and how the body handles it. It includes both healthy people and those with mild high blood pressure, and may help lower blood pressure in the future.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.